Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Frankfurt - Delayed Quote EUR

Neurocrine Biosciences, Inc. (NB3.F)

Compare
92.20
-3.86
(-4.02%)
At close: April 4 at 8:11:21 AM GMT+2
All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
595,400
595,400
389,900
339,400
256,500
Investing Cash Flow
-126,800
-126,800
-467,100
-177,100
-130,200
Financing Cash Flow
-486,700
-486,700
65,300
-234,300
27,400
End Cash Position
241,000
241,000
259,100
270,700
344,000
Income Tax Paid Supplemental Data
217,500
217,500
51,500
14,400
5,100
Interest Paid Supplemental Data
1,600
1,600
3,800
6,600
8,600
Capital Expenditure
-38,200
-38,200
-28,300
-16,500
-23,400
Repayment of Debt
-308,800
-308,800
--
-279,000
-100
Repurchase of Capital Stock
-300,000
-300,000
--
--
--
Free Cash Flow
557,200
557,200
361,600
322,900
233,100
12/31/2021 - 1/27/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade